Cargando…

Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound

The healing of chronic wound infections, especially cutaneous wounds, involves a complex cascade of events demanding mutual interaction between immunity and other natural host processes. Wound infections are caused by the consortia of microbial species that keep on proliferating and produce various...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Suhasini, Nag, Moupriya, Lahiri, Dibyajit, Pandit, Soumya, Sarkar, Tanmay, Pati, Siddhartha, Nirmal, Nilesh Prakash, Edinur, Hisham Atan, Kari, Zulhisyam Abdul, Ahmad Mohd Zain, Muhammad Rajaei, Ray, Rina Rani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911807/
https://www.ncbi.nlm.nih.gov/pubmed/35269266
http://dx.doi.org/10.3390/nano12050778
_version_ 1784666928786178048
author Mallick, Suhasini
Nag, Moupriya
Lahiri, Dibyajit
Pandit, Soumya
Sarkar, Tanmay
Pati, Siddhartha
Nirmal, Nilesh Prakash
Edinur, Hisham Atan
Kari, Zulhisyam Abdul
Ahmad Mohd Zain, Muhammad Rajaei
Ray, Rina Rani
author_facet Mallick, Suhasini
Nag, Moupriya
Lahiri, Dibyajit
Pandit, Soumya
Sarkar, Tanmay
Pati, Siddhartha
Nirmal, Nilesh Prakash
Edinur, Hisham Atan
Kari, Zulhisyam Abdul
Ahmad Mohd Zain, Muhammad Rajaei
Ray, Rina Rani
author_sort Mallick, Suhasini
collection PubMed
description The healing of chronic wound infections, especially cutaneous wounds, involves a complex cascade of events demanding mutual interaction between immunity and other natural host processes. Wound infections are caused by the consortia of microbial species that keep on proliferating and produce various types of virulence factors that cause the development of chronic infections. The mono- or polymicrobial nature of surface wound infections is best characterized by its ability to form biofilm that renders antimicrobial resistance to commonly administered drugs due to poor biofilm matrix permeability. With an increasing incidence of chronic wound biofilm infections, there is an urgent need for non-conventional antimicrobial approaches, such as developing nanomaterials that have intrinsic antimicrobial-antibiofilm properties modulating the biochemical or biophysical parameters in the wound microenvironment in order to cause disruption and removal of biofilms, such as designing nanomaterials as efficient drug-delivery vehicles carrying antibiotics, bioactive compounds, growth factor antioxidants or stem cells reaching the infection sites and having a distinct mechanism of action in comparison to antibiotics—functionalized nanoparticles (NPs) for better incursion through the biofilm matrix. NPs are thought to act by modulating the microbial colonization and biofilm formation in wounds due to their differential particle size, shape, surface charge and composition through alterations in bacterial cell membrane composition, as well as their conductivity, loss of respiratory activity, generation of reactive oxygen species (ROS), nitrosation of cysteines of proteins, lipid peroxidation, DNA unwinding and modulation of metabolic pathways. For the treatment of chronic wounds, extensive research is ongoing to explore a variety of nanoplatforms, including metallic and nonmetallic NPs, nanofibers and self-accumulating nanocarriers. As the use of the magnetic nanoparticle (MNP)-entrenched pre-designed hydrogel sheet (MPS) is found to enhance wound healing, the bio-nanocomposites consisting of bacterial cellulose and magnetic nanoparticles (magnetite) are now successfully used for the healing of chronic wounds. With the objective of precise targeting, some kinds of “intelligent” nanoparticles are constructed to react according to the required environment, which are later incorporated in the dressings, so that the wound can be treated with nano-impregnated dressing material in situ. For the effective healing of skin wounds, high-expressing, transiently modified stem cells, controlled by nano 3D architectures, have been developed to encourage angiogenesis and tissue regeneration. In order to overcome the challenge of time and dose constraints during drug administration, the approach of combinatorial nano therapy is adopted, whereby AI will help to exploit the full potential of nanomedicine to treat chronic wounds.
format Online
Article
Text
id pubmed-8911807
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89118072022-03-11 Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound Mallick, Suhasini Nag, Moupriya Lahiri, Dibyajit Pandit, Soumya Sarkar, Tanmay Pati, Siddhartha Nirmal, Nilesh Prakash Edinur, Hisham Atan Kari, Zulhisyam Abdul Ahmad Mohd Zain, Muhammad Rajaei Ray, Rina Rani Nanomaterials (Basel) Review The healing of chronic wound infections, especially cutaneous wounds, involves a complex cascade of events demanding mutual interaction between immunity and other natural host processes. Wound infections are caused by the consortia of microbial species that keep on proliferating and produce various types of virulence factors that cause the development of chronic infections. The mono- or polymicrobial nature of surface wound infections is best characterized by its ability to form biofilm that renders antimicrobial resistance to commonly administered drugs due to poor biofilm matrix permeability. With an increasing incidence of chronic wound biofilm infections, there is an urgent need for non-conventional antimicrobial approaches, such as developing nanomaterials that have intrinsic antimicrobial-antibiofilm properties modulating the biochemical or biophysical parameters in the wound microenvironment in order to cause disruption and removal of biofilms, such as designing nanomaterials as efficient drug-delivery vehicles carrying antibiotics, bioactive compounds, growth factor antioxidants or stem cells reaching the infection sites and having a distinct mechanism of action in comparison to antibiotics—functionalized nanoparticles (NPs) for better incursion through the biofilm matrix. NPs are thought to act by modulating the microbial colonization and biofilm formation in wounds due to their differential particle size, shape, surface charge and composition through alterations in bacterial cell membrane composition, as well as their conductivity, loss of respiratory activity, generation of reactive oxygen species (ROS), nitrosation of cysteines of proteins, lipid peroxidation, DNA unwinding and modulation of metabolic pathways. For the treatment of chronic wounds, extensive research is ongoing to explore a variety of nanoplatforms, including metallic and nonmetallic NPs, nanofibers and self-accumulating nanocarriers. As the use of the magnetic nanoparticle (MNP)-entrenched pre-designed hydrogel sheet (MPS) is found to enhance wound healing, the bio-nanocomposites consisting of bacterial cellulose and magnetic nanoparticles (magnetite) are now successfully used for the healing of chronic wounds. With the objective of precise targeting, some kinds of “intelligent” nanoparticles are constructed to react according to the required environment, which are later incorporated in the dressings, so that the wound can be treated with nano-impregnated dressing material in situ. For the effective healing of skin wounds, high-expressing, transiently modified stem cells, controlled by nano 3D architectures, have been developed to encourage angiogenesis and tissue regeneration. In order to overcome the challenge of time and dose constraints during drug administration, the approach of combinatorial nano therapy is adopted, whereby AI will help to exploit the full potential of nanomedicine to treat chronic wounds. MDPI 2022-02-25 /pmc/articles/PMC8911807/ /pubmed/35269266 http://dx.doi.org/10.3390/nano12050778 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mallick, Suhasini
Nag, Moupriya
Lahiri, Dibyajit
Pandit, Soumya
Sarkar, Tanmay
Pati, Siddhartha
Nirmal, Nilesh Prakash
Edinur, Hisham Atan
Kari, Zulhisyam Abdul
Ahmad Mohd Zain, Muhammad Rajaei
Ray, Rina Rani
Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title_full Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title_fullStr Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title_full_unstemmed Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title_short Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound
title_sort engineered nanotechnology: an effective therapeutic platform for the chronic cutaneous wound
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911807/
https://www.ncbi.nlm.nih.gov/pubmed/35269266
http://dx.doi.org/10.3390/nano12050778
work_keys_str_mv AT mallicksuhasini engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT nagmoupriya engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT lahiridibyajit engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT panditsoumya engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT sarkartanmay engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT patisiddhartha engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT nirmalnileshprakash engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT edinurhishamatan engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT karizulhisyamabdul engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT ahmadmohdzainmuhammadrajaei engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound
AT rayrinarani engineerednanotechnologyaneffectivetherapeuticplatformforthechroniccutaneouswound